Abbott Explains Continuous Glucose Monitoring Technology

Abbott Laboratories has published an explanation of continuous glucose monitoring (CGM) technology, offering individuals with diabetes new tools for managing their condition. The company states that the technology has advanced significantly, with new devices capable of alerting users to unusual glucose levels and transmitting data to healthcare providers.

The explanation covers key terms related to CGM technology, including alarms, calibration, data sharing, trending, and sensors. Abbott's FreeStyle Libre 2 system is noted for providing alerts for low or high glucose levels and does not require regular calibration through traditional fingersticks. Data-sharing capabilities allow users and their loved ones to make informed decisions, and data can also be shared with care teams for remote monitoring.

The article highlights the "Time in Glucose Range" metric, which measures the percentage of time a patient spends within their physician-defined optimal glucose level range. This metric is presented as a crucial tool for assessing diabetes control and guiding treatment.

Abbott indicates that these technological advancements aim to simplify daily diabetes management and empower patients to focus on living their lives. The company also includes important safety information and device limitations.